who manufactures tradjenta
Tradjenta and Jentadueto belong to a family of drugs called DPP-4 inhibitors. The drugs are linked to pancreatitis and may also increase the risk of pancreatic cancer. Tradjenta (linagliptin) is an oral prescription medication manufactured by Boehringer Ingelheim and Eli Lilly for the treatment of type 2 diabetes. Tradjenta lowers blood sugar, and doctors can prescribe it alongside other diabetes drugs like Actos, metformin and insulin.